A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

por Tsukiyama, Ikuto, Ejiri, Masayuki, Yamamoto, Yoshihiro, Nakao, Haruhisa, Yoneda, Masashi, Matsuura, Katsuhiko, Arakawa, Ichiro, Saito, Hiroko, Inoue, Tadao
Publicado 2016

Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia

por Tsukiyama, Ikuto, Iwata, Takashi, Takeuchi, Tomoko, Kato, Ryoko Inuzuka, Sakuma, Masaki, Tsukiyama, Sumiyo, Kato, Mana, Ikeda, Yoshiaki, Ohashi, Wataru, Kubo, Akihito, Mori, Naoharu
Publicado 2023

Cost‐effectiveness of aprepitant in Japanese patients treated with cisplatin‐containing highly emetogenic chemotherapy

por Tsukiyama, Ikuto, Hasegawa, Shiori, Ikeda, Yoshiaki, Takeuchi, Masayuki, Tsukiyama, Sumiyo, Kurose, Yusuke, Ejiri, Masayuki, Sakuma, Masaki, Saito, Hiroko, Arakawa, Ichiro, Inoue, Tadao, Yamaguchi, Etsuro, Kubo, Akihito
Publicado 2018